Literature DB >> 7650179

Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci.

F C Tenover1, J M Swenson, C M O'Hara, S A Stocker.   

Abstract

We evaluated the abilities of 10 commercially available antimicrobial susceptibility testing methods and four reference methods (agar dilution, broth microdilution, disk diffusion, and the agar screen plate) to classify enterococci correctly as vancomycin susceptible or resistant using 50 well-characterized strains of enterococci. There was a high level of agreement of category classification data obtained with broth-based systems (Sceptor, MicroMedia, Pasco, and Sensititre), agar dilution, and an antibiotic gradient method (E test) with data obtained by reference broth microdilution; no very major or major errors were seen, and minor errors were < or = 6%. Increased minor error rates were observed with disk diffusion (12%), Alamar (16%), Uniscept (16%), and conventional (overnight) MicroScan panels (16%). The errors were primarily with Enterococcus casseliflavus strains and organisms containing the vanB vancomycin resistance gene. Very major error rates of 10.3 and 20.7% were observed with Vitek and MicroScan Rapid (MS/Rapid) systems, respectively; however, only the MS/Rapid system produced major errors (13.3%). On repeat testing of discrepant isolates, the very major error rate with the Vitek system dropped to 3.4%, while the very major error rate with the MS/Rapid system increased to 27.6%; major errors with the MS/Rapid system were not resolved. Many of the commercial systems had only 4 dilutions of vancomycin, which resulted in up to 84% of values being off scale (e.g., Uniscept). Of the methods tested, most conventional broth- and agar-based methods proved to be highly accurate when incubation was done for a full 24 h, although several of the tests had high minor error rates. Automated systems continued to demonstrate problems in detecting low-level resistance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650179      PMCID: PMC228208          DOI: 10.1128/jcm.33.6.1524-1527.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  In vitro detection of enterococcal vancomycin resistance.

Authors:  D F Sahm; L Olsen
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

2.  Identification of Enterococcus species isolated from human infections by a conventional test scheme.

Authors:  R R Facklam; M D Collins
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

3.  Detection of vancomycin resistance in Enterococcus species.

Authors:  B M Willey; B N Kreiswirth; A E Simor; G Willaims; S R Scriver; A Phillips; D E Low
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

4.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

5.  Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit.

Authors:  M A Montecalvo; H Horowitz; C Gedris; C Carbonaro; F C Tenover; A Issah; P Cook; G P Wormser
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

6.  Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci.

Authors:  F C Tenover; J Tokars; J Swenson; S Paul; K Spitalny; W Jarvis
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

7.  Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents.

Authors:  M B Huang; C N Baker; S Banerjee; F C Tenover
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

8.  Development of a standardized screening method for detection of vancomycin-resistant enterococci.

Authors:  J M Swenson; N C Clark; M J Ferraro; D F Sahm; G Doern; M A Pfaller; L B Reller; M P Weinstein; R J Zabransky; F C Tenover
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

9.  Characterization of glycopeptide-resistant enterococci from U.S. hospitals.

Authors:  N C Clark; R C Cooksey; B C Hill; J M Swenson; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

10.  Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens.

Authors:  F Navarro; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

View more
  22 in total

1.  Unacceptable performance and the lack of reproducibility results in the report of colorimetric methods for early detection of vancomycin and oxacillin resistance in Staphylococcus aureus.

Authors:  Ibrahim C Acuner; Cafer Eroglu
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Are clinical laboratories in California accurately reporting vancomycin-resistant enterococci?

Authors:  J Rosenberg; F C Tenover; J Wong; W Jarvis; D J Vugia
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

3.  Factors influencing the vitek gram-positive susceptibility system's detection of vanB-encoded vancomycin resistance among enterococci.

Authors:  B Jett; L Free; D F Sahm
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

4.  Determination of the antibacterial and lipopolysaccharide-neutralizing regions of guinea pig neutrophil cathelicidin peptide CAP11.

Authors:  Daiju Okuda; Shin Yomogida; Hiroshi Tamura; Isao Nagaoka
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 5.  Recent advances: medical microbiology.

Authors:  H Richardson; F Smaill
Journal:  BMJ       Date:  1998-10-17

6.  Evaluation of commercial vancomycin agar screen plates for detection of vancomycin-resistant enterococci.

Authors:  K G Van Horn; C A Gedris; K M Rodney; J B Mitchell
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

Review 7.  Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia?

Authors:  Andrea Endimiani; Kristine M Hujer; Andrea M Hujer; Sebastian Kurz; Michael R Jacobs; David S Perlin; Robert A Bonomo
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

8.  Evaluation of Alamar colorimetric broth microdilution susceptibility testing method for staphylococci and enterococci.

Authors:  C N Baker; F C Tenover
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

9.  Discrepancy in antimicrobial susceptibility test results obtained for oral streptococci with the Etest and agar dilution.

Authors:  Eiman M Mokaddas; Nathaneal O Salako; Leeba Philip; Vincent O Rotimi
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

10.  Proficiency of clinical laboratories in and near Monterrey, Mexico, to detect vancomycin-resistant enterococci.

Authors:  L C McDonald; L R Garza; W R Jarvis
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.